Michael Latwis

RealMoney.com Contributor

Michael Latwis directed health care content at TheStreet.com Professional Products. He also has worked at Barclays Wealth management division and was previously associated with Lazard Freres and Fiduciary Trust. Latwis covered companies in the pharmaceutical and specialty pharmaceutical sectors as well as biotech, medical technology, healthcare services, retail and media stocks. He has an MBA from Pace University.

Michael Latwis
By This Author:
« Back
Page 1 of 1
Next »
Video

Wall Street Wary of Amgen

By Michael Latwis

However, today's report gives management a chance to deflate the cloud of negative sentiment.

01:43PM 04/18/06

Video

A Look Ahead at Genentech

By Michael Latwis

This biotech bellwether should still show an above-normal pace of earnings growth, says Mike Latwis.

11:02AM 04/11/06

Video

A Preview of Medtronic

By Michael Latwis

Mike Latwis tells you what to listen for in tonight's call.

11:49AM 02/21/06

Video

A Preview of Barr's Call

By Michael Latwis

Michael Latwis tells you what to listen for in the generic drugmaker's report.

03:12PM 02/06/06

« Back
Page 1 of 1
Next »
Dow Jones S&P 500 NASDAQ 10-Year Note
10,453.21 1,107.11 2,167.78 32.36
Oil *
79.78
UP
108.37
UP
11.48
UP
23.18
UP
0.35
10 Yr
3.24%
SPDR Gold
115.65
+1.05%
+1.05%
+1.08%
+1.09%
Data delayed 20 minutes

Brokerage Partners